News Ablynx and Sanofi sign potential 2.4bn euro R&D deal Collaboration will develop drugs for inflammatory diseases
News Amicus to file Fabry drug after FDA changes mind Regulator drops demand for further phase 3 trial.
News Sanofi $750m acquisition gives it edge in flu vacccine marke... Biotech's Flublok is only FDA-approved cell-based flu jab
News Sanofi's RA drug Kevzara approved in Europe Sanofi’s next-generation rheumatoid arthritis drug Kevzara has been approved in Europe, giving a new option for patients who are intolerant to other treatments.
News Parexel and Sanofi collaborate on wearables study Study will focus on PAREXEL's Perceptive MyTrials platform for gathering wearables data.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.